Saints Capital Granite, L.p. - Net Worth and Insider Trading

Saints Capital Granite, L.p. Net Worth

The estimated net worth of Saints Capital Granite, L.p. is at least $25 Million dollars as of 2024-03-29. Saints Capital Granite, L.p. is the 10% Owner of Enanta Pharmaceuticals Inc and owns about 1,425,708 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $25 Million. Details can be seen in Saints Capital Granite, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Saints Capital Granite, L.p. has not made any transactions after 2013-10-14 and currently still holds the listed stock(s).

Transaction Summary of Saints Capital Granite, L.p.

To

Saints Capital Granite, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Saints Capital Granite, L.p. owns 1 companies in total, including Enanta Pharmaceuticals Inc () .

Click here to see the complete history of Saints Capital Granite, L.p.’s form 4 insider trades.

Insider Ownership Summary of Saints Capital Granite, L.p.

Ticker Comapny Transaction Date Type of Owner
Enanta Pharmaceuticals Inc 2013-10-14 10 percent owner

Saints Capital Granite, L.p. Latest Holdings Summary

Saints Capital Granite, L.p. currently owns a total of 1 stock. Saints Capital Granite, L.p. owns 1,425,708 shares of Enanta Pharmaceuticals Inc (ENTA) as of October 14, 2013, with a value of $25 Million.

Latest Holdings of Saints Capital Granite, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTA Enanta Pharmaceuticals Inc 2013-10-14 1,425,708 17.43 24,850,090

Holding Weightings of Saints Capital Granite, L.p.


Saints Capital Granite, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Saints Capital Granite, L.p. has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 32,301 shares on October 14, 2013, which brought Saints Capital Granite, L.p. around $640,852.

Insider Trading History of Saints Capital Granite, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Saints Capital Granite, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Saints Capital Granite, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saints Capital Granite, L.p. is 6.5%. GuruFocus also compares Saints Capital Granite, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Saints Capital Granite, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Saints Capital Granite, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Saints Capital Granite, L.p.

Average Relative Return

127.5%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 20.66 6.5 36.28 127.5 36.37 16.53
Relative Return to S&P 500(%) 19.48 3.97 27.65 109.03 21.7 7.33

Saints Capital Granite, L.p. Ownership Network

Ownership Network List of Saints Capital Granite, L.p.

No Data

Ownership Network Relation of Saints Capital Granite, L.p.


Saints Capital Granite, L.p. Owned Company Details

What does Enanta Pharmaceuticals Inc do?

Who are the key executives at Enanta Pharmaceuticals Inc?

Saints Capital Granite, L.p. is the 10 percent owner of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & Business Dev. Brendan Luu , and Sr. VP & New Product Dev. Tara Lynn Kieffer .

Enanta Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Saints Capital Granite, L.p. made no insider transaction in Enanta Pharmaceuticals Inc (). Other recent insider transactions involving Enanta Pharmaceuticals Inc () include a net sale of 65,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .

In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,822 shares of Enanta Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,822 shares.

Enanta Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enanta Pharmaceuticals Inc Insider Transactions

No Available Data

Saints Capital Granite, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Saints Capital Granite, L.p.. You might contact Saints Capital Granite, L.p. via mailing address: 475 Sansome Street, Suite 1850, San Francisco Ca 94111.

Discussions on Saints Capital Granite, L.p.

No discussions yet.